Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately.

The 2016 RCTs showed a trend toward higher percentage of participants completing the trials ( table 2 ).

also in 53,322 other papers

Lack of a significant trend in improved reporting 10 years apart remains a major concern.

also in 9,775 other papers